Us Bancorp \De\ Gamida Cell Ltd. Transaction History

Us Bancorp \De\

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.73 - $2.37 $878 - $2,853	-1,204 Reduced 60.08%	800 $1,000
Q1 2022 May 11, 2022	BUY	$2.22 - $4.47 $1,776 - $3,576	800 Added 66.45%	2,004 $8,000
Q3 2020 Nov 10, 2020	BUY	$3.93 - $4.59 $4,731 - $5,526	1,204 New	1,204 $5,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.